Type in a keyword and see the report right away. Explore your online world!
If you have already a Newsmeter account:
You can free sign up for Newsmeter:
x
Drugmakers are capitalizing on the success of groundbreaking obesity drugs with plans to release an additional 13 treatments in the coming years. Starting this year, the number of new obesity drugs hi...
04.23.2024 Dailymail.co.uk and 3 sites
Mr. Ramanayake brings more than fifteen years of experience in biopharma company development and deal-making Strong track record of successful clinical collaborations, M&A, asset in-licensing and stra...
04.24.2024 Eqs-news.com and 100 sites
Verdence Capital Advisors LLC grew its position in Valero Energy Co. ( NYSE: VLO – Free Report ) by 20. 9% during the 4th quarter, according to the company in its most recent filing with the Securitie...
04.21.2024 Transcriptdaily.com and 106 sites
Loading. . . Loading. . . A recent academic case study, published on April 22, examined using Amgen Inc’s AMGN Blincyto, a bispecific CD3xCD19 T-cell engager, to treat a patient with severe systemic s...
04.24.2024 investing.com , yahoo.com and 2 sites
RIA Advisory Group LLC boosted its holdings in shares of Amgen Inc. ( NASDAQ: AMGN – Free Report ) by 8. 7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 6, 128 shares of the medical research company’s stock after acquiring an additional 492 shares during the period. Amgen comprises 0. 5% of RIA Advisory Group LLC’s portfolio, making the stock its 28th largest holding. RIA Advisory Group LLC’s holdin...
04.19.2024 Techdows.com and 80 sites
OLD National Bancorp IN trimmed its stake in Amgen Inc. ( NASDAQ: AMGN – Free Report ) by 2. 0% in the fourth quarter, HoldingsChannel. com reports. The firm owned 8, 187 shares of the medical researc...
04.21.2024 Thecerbatgem.com and 59 sites
Organizational redesign and rightsizing initiated across company to streamline structures, increase efficiency and reduce operating costs Together with GSK, ended Pandemic Preparedness Agreement (PPA)...
04.24.2024 Tradingview.com and 40 sites
Amgen has been in pullback mode since the beginning of February, losing roughly 13% within the context of its long-term uptrend. For those interested in 'buying the dip, ' this may be a good time to r...
04.22.2024 Cnbc.com and 2 sites
Kiniksa Pharmaceuticals (NASDAQ: KNSA ) has reported a significant increase in its financial performance for the first quarter of 2024, with an 85% rise in net product revenue from its leading drug AR...
04.24.2024 Investing.com and 3 sites
Driving The Day DRUGMAKERS DOMINATE TOP LOBBYING SPENDERS — The pharmaceutical industry bolstered its lobbying spending in the first three months of 2024 compared with the same period in 2023, according to newly filed disclosures, POLITICO’s Megan R....
04.24.2024 Politico.com
